Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.
about
One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason gradingGenome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.Occupation, industry, and the risk of prostate cancer: a case-control study in Montréal, Canada.Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.Sunlight exposure during leisure activities and risk of prostate cancer in Montréal, Canada, 2005-2009.Circumcision and prostate cancer: a population-based case-control study in Montréal, CanadaStatin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, CanadaIncreased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms-A whole of population study.Predicting bone scan positivity in non-metastatic castration-resistant prostate cancerAutomatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.Biochemical recurrence in Gleason score 7 prostate cancer in korean men: significance of the primary Gleason grade.Trends in prostate cancer in the United States.Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptakeHOXB13 mutations in a population-based, case-control study of prostate cancer.Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy.Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men.Epstein criteria for insignificant prostate cancer.Active surveillance in prostate cancer: the need to standardize.Prostate cancer epidemiology in the United States.L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancer.Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer.Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database.Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer.Perceived Workplace Stress Is Associated with an Increased Risk of Prostate Cancer before Age 65.The performance of the new prognostic grade and stage groups in conservatively treated prostate cancer.PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer.The effect of Rapid Access Prostate Clinics on the outcomes of Gleason 7 prostate cancer: does earlier diagnosis lead to better outcomes?Association Analysis of a Microsatellite Repeat in the Gene With Prostate Cancer Risk, Aggressiveness and SurvivalVitamin C Intake and Risk of Prostate Cancer: The Montreal PROtEuS Study
P2860
Q28070143-CF043A8F-4A73-4D66-A420-82EC2655A020Q30500998-6769CE4A-FACE-42BE-A783-A6E1E40A5002Q30825443-1A9A9104-D6D5-41C5-9BD8-198AB12736C4Q33896203-CE5AED81-9E8B-4D35-A6B3-C4E212360CE6Q34006846-1B6B11CD-40E4-4172-9BF7-A8381A04E33CQ34040268-E4A85AF8-F4D8-45C8-8877-6ED5CF2CFD34Q34502662-E5335CC7-6B3C-4F50-A20F-ED437EC06160Q35322421-F1FF982F-BF68-4755-B619-4879FA9DD0D0Q35781093-07DE0838-73C2-4260-B847-FD61AB187ED9Q36106227-5CEBF41B-F474-4D85-9957-30CDB84BF85AQ36268971-015BCCEA-A1A2-48D0-9994-61D0D7B68AB5Q36306100-A7311A32-937E-4C62-853A-F784235087BBQ36492460-7394C605-6037-4B85-9336-BC3F3B3AD373Q36520517-832294D0-96DD-454E-A54D-183201E35003Q36533826-7E075894-8465-48E5-BB87-4ACB324B4018Q36728798-355EA2B5-C421-4701-A7DB-717C7976E512Q36946259-7FA842CB-F2B8-4C11-B580-B19D08A68A92Q37408547-3EE525E9-99CE-4877-9778-AFA2CF12C368Q37841742-CF3920DC-71B4-4367-81A6-B5F4B488098EQ37882461-501D3DBF-2151-4BC5-93EC-A2371DCCFED0Q38000053-9E5D1696-D65A-48EF-A836-08AF117BEFADQ38292729-EA832E67-89AB-40ED-BFE9-132EE4E24F60Q39367982-B1CB3953-B438-4DCA-BF1B-691885031DEAQ40243618-80690914-8A14-49F8-95F1-A2826FE58AD7Q40674443-EDEC82D1-4B24-4D6C-BAD1-085750AFC135Q41486847-B3B8D1F5-7FC8-4757-99CA-EB687D36C2E7Q41551668-403B16AE-0AE7-4038-BA0E-1D6D6EAFCB94Q43533918-24D250CF-BF13-49F3-BF75-46AE3E87F2D5Q44285666-0AA0725E-713C-41EB-9CBF-5EDC8FB827BBQ47156498-0C5147AE-39B8-4E1B-831E-4023848C23C1Q52679869-91576A77-3AD1-41F4-BB2C-25F40C222ABFQ52727709-2BCC2141-5071-4BB6-9DDA-585D97C8ADC3Q53195658-2BE952E0-F905-44C4-8A14-0576FFCCC03CQ53687040-7B8EC647-8726-487A-AC00-E0F585BB1B7EQ53785684-FB74E0F1-9695-4DCB-957C-05CA7125D074Q58583792-4183788E-8B79-468F-B7B1-CA5DC3A387C1Q58764802-267858BA-791F-480A-9AC1-C65721C41F1C
P2860
Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostate cancer specific morta ...... in a population based cohort.
@en
Prostate cancer specific morta ...... in a population based cohort.
@nl
type
label
Prostate cancer specific morta ...... in a population based cohort.
@en
Prostate cancer specific morta ...... in a population based cohort.
@nl
prefLabel
Prostate cancer specific morta ...... in a population based cohort.
@en
Prostate cancer specific morta ...... in a population based cohort.
@nl
P2093
P2860
P1476
Prostate cancer specific morta ...... in a population based cohort.
@en
P2093
Claudia A Salinas
Daniel W Lin
Janet L Stanford
Jonathan L Wright
Joseph Koopmeiners
Suzanne Kolb
Ziding Feng
P2860
P304
P356
10.1016/J.JURO.2009.08.026
P407
P577
2009-12-01T00:00:00Z